Endo International PLC (ENDP): Price and Financial Metrics


Endo International PLC (ENDP): $0.47

0.00 (-0.19%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ENDP POWR Grades


  • Growth is the dimension where ENDP ranks best; there it ranks ahead of 99.53% of US stocks.
  • ENDP's strongest trending metric is Momentum; it's been moving down over the last 179 days.
  • ENDP's current lowest rank is in the Sentiment metric (where it is better than 3.07% of US stocks).

ENDP Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for ENDP is -2.41 -- better than merely 3.07% of US stocks.
  • ENDP's price/sales ratio is 0.2; that's higher than the P/S ratio of merely 2.77% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -11.57 for Endo International plc; that's greater than it is for only 1.65% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Endo International plc are LNDC, AGFS, ERJ, AIMC, and BVN.
  • ENDP's SEC filings can be seen here. And to visit Endo International plc's official web site, go to www.endo.com.

ENDP Valuation Summary

  • ENDP's price/sales ratio is 0.2; this is 98.24% lower than that of the median Healthcare stock.
  • ENDP's EV/EBIT ratio has moved up 23.1 over the prior 243 months.
  • ENDP's price/sales ratio has moved down 4 over the prior 243 months.

Below are key valuation metrics over time for ENDP.

Stock Date P/S P/B P/E EV/EBIT
ENDP 2021-08-31 0.2 -0.9 7.7 14.9
ENDP 2021-08-30 0.2 -0.9 7.7 14.9
ENDP 2021-08-27 0.2 -0.9 7.8 14.9
ENDP 2021-08-26 0.2 -0.9 8.1 14.9
ENDP 2021-08-25 0.2 -1.0 8.5 15.0
ENDP 2021-08-24 0.2 -1.0 8.9 15.0

ENDP Growth Metrics

    Its 2 year revenue growth rate is now at -3.75%.
  • The 5 year cash and equivalents growth rate now stands at 132.84%.
  • Its 5 year net cashflow from operations growth rate is now at 146.24%.
Over the past 34 months, ENDP's revenue has gone up $26,244,000.

The table below shows ENDP's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 2,993.206 411.05 -613.245
2021-09-30 2,963.998 568.863 68.16
2021-06-30 2,826.83 429.32 69.48
2021-03-31 2,800.588 578.676 95.538
2020-12-31 2,903.074 397.392 183.944
2020-09-30 2,907.653 268.251 -154.042

ENDP's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ENDP has a Quality Grade of C, ranking ahead of 34.17% of graded US stocks.
  • ENDP's asset turnover comes in at 0.307 -- ranking 148th of 682 Pharmaceutical Products stocks.
  • CEMI, NEOG, and PAHC are the stocks whose asset turnover ratios are most correlated with ENDP.

The table below shows ENDP's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.307 0.525 0.057
2021-03-31 0.304 0.515 0.058
2020-12-31 0.315 0.503 0.051
2020-09-30 0.314 0.493 0.028
2020-06-30 0.319 0.496 0.029
2020-03-31 0.312 0.480 0.016

ENDP Price Target

For more insight on analysts targets of ENDP, see our ENDP price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.57 Average Broker Recommendation 2 (Hold)

ENDP Stock Price Chart Interactive Chart >

Price chart for ENDP

ENDP Price/Volume Stats

Current price $0.47 52-week high $7.07
Prev. close $0.47 52-week low $0.34
Day low $0.45 Volume 12,292,603
Day high $0.50 Avg. volume 6,857,862
50-day MA $1.87 Dividend yield N/A
200-day MA $3.29 Market Cap 110.50M

Endo International PLC (ENDP) Company Bio


Endo International plc focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals. The company was founded in 1920 and is based in Dublin, Ireland.


ENDP Latest News Stream


Event/Time News Detail
Loading, please wait...

ENDP Latest Social Stream


Loading social stream, please wait...

View Full ENDP Social Stream

Latest ENDP News From Around the Web

Below are the latest news stories about Endo International plc that investors may wish to consider to help them evaluate ENDP as an investment opportunity.

Endo (ENDP) to Report Q4 Earnings: What's in the Cards?

Endo's (ENDP) fourth-quarter earnings might have gained from higher sales of Xiaflex.

Yahoo | February 23, 2022

Analysts Estimate Endo International (ENDP) to Report a Decline in Earnings: What to Look Out for

Endo (ENDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 21, 2022

Endo International (ENDP) Stock Moves -0.65%: What You Should Know

Endo International (ENDP) closed at $3.08 in the latest trading session, marking a -0.65% move from the prior day.

Yahoo | February 18, 2022

Convey Health Solutions Holdings, Inc. Appoints Paul V. Campanelli to Board of Directors

FORT LAUDERDALE, Fla. , Feb. 15, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE: CNVY ) ("Convey"), a leading healthcare technology and services company, today announced the appointment of Paul Campanelli to its Board of Directors ("Board"). Mr. Campanelli has approximately 30 years of experience in the healthcare industry, including leadership positions in both publicly held and private equity controlled companies. Mr. Campanelli previously served as Chairman of the Board of Endo International ("Endo") from November 2019 to June 2021 , and previously served as President and Chief Executive Officer of Endo from September 2016 to March 2020 . While acting as Chief Executive Officer, Mr. Campanelli focused on executing Endo''s strategy to improve productivity, simplify ...

Benzinga | February 15, 2022

Is Endo International (ENDP) A Great Long-Term Investment?

Miller Value Partners, an investment management firm, published its Miller Deep Value Strategy fourth quarter 2021 investor letter a copy of which can be seen here.

Insider Monkey | February 14, 2022

Read More 'ENDP' Stories Here

ENDP Price Returns

1-mo -78.04%
3-mo -85.54%
6-mo -91.94%
1-year -91.99%
3-year -91.58%
5-year -96.42%
YTD -87.50%
2021 -47.63%
2020 53.09%
2019 -35.75%
2018 -5.81%
2017 -52.94%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6051 seconds.